MINI-FUTURE LONG - ELI LILLY & CO Stock

Certificat

LLYCNU

CH1292908659

Market Closed - Swiss Exchange 11:20:00 2024-06-14 EDT
3.56 CHF +1.14% Intraday chart for MINI-FUTURE LONG - ELI LILLY & CO
Current month+16.72%
1 month+42.40%
Date Price Change
24-06-14 3.56 +1.14%
24-06-13 3.52 +3.23%
24-06-11 3.41 +1.19%
24-06-10 3.37 +2.43%
24-06-07 3.29 +2.81%

Delayed Quote Swiss Exchange

Last update June 14, 2024 at 11:20 am

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying ELI LILLY AND COMPANY
Issuer UBS
LLYCNU
ISINCH1292908659
Date issued 2023-09-01
Strike 483.6 $
Maturity Unlimited
Parity 100 : 1
Emission price 0.89 CHF
Emission volume N/A
Settlement cash
Currency CHF

Technical Indicators

Highest since issue 3.56 CHF
Lowest since issue 0.64 CHF
Spread 0.01 CHF
Spread %0.28%

Company Profile

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunology diseases (11.1%); - neurology (8.4%): primarily drugs used in treating depression and schizophrenia; - other (3.3%). Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
More about the company

Ratings for Eli Lilly and Company

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Eli Lilly and Company

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
878.4 USD
Average target price
855.4 USD
Spread / Average Target
-2.63%
Consensus
  1. Stock Market
  2. Certificates
  3. LLYCNU Certificat